Company Number: 12751828

Analysis Date: 2025-07-29 15:06 UTC

Financial Health Assessment of THE PPE PROCUREMENT GROUP LIMITED

---

1. Financial Health Score: C (Fair)

Explanation:
The company shows a stable but weak financial position. While it maintains positive net assets and shareholder funds, the cash position is fragile with net current liabilities indicating liquidity stress. There are no major warning signs of insolvency yet, but symptoms suggest cash flow challenges and potential difficulties covering short-term obligations without additional funding or operational improvements.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Fixed Assets (Intangible)	£1,732	Significant investment in intangible assets (likely R&D or intellectual property)
Current Assets (Cash)	£237	Very low cash reserves, limiting operational flexibility
Current Liabilities	£354	Short-term debts exceed cash, causing net current liabilities of -£117
Net Current Assets	-£117	Negative working capital, indicating liquidity pressure
Net Assets (Shareholders Funds)	£1,615	Positive equity, but decreased from £1,904 in 2023
Share Capital	£2,000	Stable capital base, but low overall equity
Income Statement Reserve	-£385	Accumulated losses increased, indicating ongoing losses
Employees	0 (Nil)	No employees, likely minimal operating overhead

---

3. Diagnosis: What the Financial Data Reveals

• Liquidity Symptoms: The company is experiencing a "symptom of distress" in its liquidity with current liabilities exceeding current assets. This negative working capital means the business may struggle to meet immediate financial obligations without resorting to external financing or delaying payments.
• Operating Health: The absence of employees and a small cash base suggests limited ongoing operations or a business model heavily reliant on outsourcing or automation. The company has been incurring losses (negative income statement reserve), which is a sign of operating challenges.
• Asset Structure: The primary assets are intangible, likely related to intellectual property or product development in the medical supplies sector. The amortisation of these assets indicates ongoing investment but also a charge reducing profit.
• Capital Structure: The company is lightly capitalized with a modest share capital and shareholder funds. The reduction in net assets from 2023 to 2024 signals either losses or asset write-downs.
• Governance: The company has stable leadership with two directors holding significant control and no indications of director disqualifications or governance issues.

Overall, the company is in a fragile financial state with limited cash resources and ongoing losses but no immediate insolvency signs.

---

4. Recommendations: Improving Financial Wellness

• Enhance Cash Flow Management: Prioritize improving cash reserves to build a healthy cash flow "heartbeat." Consider negotiating longer payment terms with creditors or accelerating receivables to ease liquidity pressure.
• Cost Control and Revenue Growth: Address ongoing losses by either reducing operating expenses or increasing sales. Given the current absence of employees, evaluate whether strategic hiring or outsourcing can improve operational efficiency and revenue.
• Seek Additional Capital or Financing: To stabilize working capital and fund growth or operations, explore options like shareholder loans, bank overdrafts, or equity injection.
• Regular Financial Monitoring: Implement monthly cash flow forecasting and key performance indicator tracking to detect symptoms of financial distress early and adjust strategy proactively.
• Review Asset Utilization: Evaluate the intangible assets' value and amortisation schedule to ensure they continue to support future earnings and are not overvalued on the balance sheet.
• Strategic Business Review: Given the business operates in the competitive and critical PPE sector, review market positioning, customer base, and product pipeline to ensure sustainable long-term viability.

---